Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hepatology communications

Showing results (1-10 of 1,984) with videos related to

Pageof 199
Sort By:
Hepatology Communications|January 6, 2026
Predictors of overall survival in advanced biliary tract cancer in the phase 3 TOPAZ-1 studyAiwu R He, Mohamed Bouattour, Vineet G Gupta, et al.
Hepatology Communications|February 3, 2025
Distribution of culture-positive microorganisms varies with severity of liver disease in patients hospitalized with SBPNadim Mahmud, Natalia Salinas Parra, Aaron L Hecht, et al.
Hepatology Communications|November 27, 2024
Issue Information
Hepatology Communications|October 17, 2022
Clinical and demographic predictors of survival for fibrolamellar carcinoma patients-A patient community, registry-based studyAmichai Berkovitz, Rachael D Migler, Adam Qureshi, et al.
Hepatology Communications|September 1, 2023
Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?Dominic Crocombe, Alastair O'Brien
Hepatology Communications|February 10, 2025
The impact of integrated care on clinical outcomes in patients with alcohol-associated liver disease: Early outcomes from a multidisciplinary clinicShreya Sengupta, Akhil Anand, Qijun Yang, et al.
Hepatology Communications|February 3, 2025
Deletion of sphingosine 1-phosphate receptor 1 in myeloid cells reduces hepatic inflammatory macrophages and attenuates MASHGopanandan Parthasarathy, Nanditha Venkatesan, Guneet Singh Sidhu, et al.
Hepatology Communications|January 29, 2025
HBV and HBsAg strongly reshape the phenotype, function, and metabolism of DCs according to patients' clinical stageLucile Dumolard, Theophile Gerster, Florent Chuffart, et al.
Hepatology Communications|January 29, 2025
Adipokines regulate the development and progression of MASLD through organellar oxidative stressKe Zhao, Heng Zhang, Wenyu Ding, et al.
Hepatology Communications|January 8, 2025
Machine-learning methodologies to predict disease progression in chronic hepatitis B in AfricaHailemichael Desalegn, Xianchen Yang, Yi-Syuan Yen, et al.
Pageof 199

Showing results (1-10 of 1,984) with videos related to

Sort By:
Pageof 199
Hepatology Communications|January 6, 2026
Predictors of overall survival in advanced biliary tract cancer in the phase 3 TOPAZ-1 studyAiwu R He, Mohamed Bouattour, Vineet G Gupta, et al.
Hepatology Communications|February 3, 2025
Distribution of culture-positive microorganisms varies with severity of liver disease in patients hospitalized with SBPNadim Mahmud, Natalia Salinas Parra, Aaron L Hecht, et al.
Hepatology Communications|November 27, 2024
Issue Information
Hepatology Communications|October 17, 2022
Clinical and demographic predictors of survival for fibrolamellar carcinoma patients-A patient community, registry-based studyAmichai Berkovitz, Rachael D Migler, Adam Qureshi, et al.
Hepatology Communications|September 1, 2023
Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?Dominic Crocombe, Alastair O'Brien
Hepatology Communications|February 10, 2025
The impact of integrated care on clinical outcomes in patients with alcohol-associated liver disease: Early outcomes from a multidisciplinary clinicShreya Sengupta, Akhil Anand, Qijun Yang, et al.
Hepatology Communications|February 3, 2025
Deletion of sphingosine 1-phosphate receptor 1 in myeloid cells reduces hepatic inflammatory macrophages and attenuates MASHGopanandan Parthasarathy, Nanditha Venkatesan, Guneet Singh Sidhu, et al.
Hepatology Communications|January 29, 2025
HBV and HBsAg strongly reshape the phenotype, function, and metabolism of DCs according to patients' clinical stageLucile Dumolard, Theophile Gerster, Florent Chuffart, et al.
Hepatology Communications|January 29, 2025
Adipokines regulate the development and progression of MASLD through organellar oxidative stressKe Zhao, Heng Zhang, Wenyu Ding, et al.
Hepatology Communications|January 8, 2025
Machine-learning methodologies to predict disease progression in chronic hepatitis B in AfricaHailemichael Desalegn, Xianchen Yang, Yi-Syuan Yen, et al.
Pageof 199